We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Tecan and VWR Announce a Strategic Alliance

By Labmedica staff writers
Posted on 12 Mar 2007
Tecan (Männedorf, Switzerland) and VWR International, Inc. More...
(West Chester, PA, USA) have announced a strategic alliance to unite the strengths of each company and together provide Tecan's microarray instruments and microplate readers to the global research market.

The collaboration takes advantage of VWR's BioSciences program, which aims to provide researchers with the highest quality services and products available, whatever their application, and a sales network throughout Europe.

Tecan's range of microarray products and microplate readers can offer solutions for customers of the BioSciences program working in all areas of life science and drug discovery. Siegfried Sasshofer, head of marketing for Tecan's Detection business unit, said, Tecan's products and technical expertise complement the VWR's BioSciences program very well, and together we can build on our respective strengths in high end instrumentation and well-developed customer relationships. The close collaboration of both teams will benefit research communities in the US and in Europe, helping them to find the best solutions and allowing them to excel in their respective fields.

Matt Malenfant, senior VP and president Global Lab Business commented, The BioSciences program is an investment by VWR to extend our offering of research instruments for our customers' drug discovery and development needs. Establishing a partnership with Tecan accomplishes this, offering an industry leader in laboratory automation and detection instrumentation to our broad reach of customers. Our mutual commitment to excellence will most certainly drive value for our customers.

Tecan specializes in the development, production, and distribution of advanced automation systems enabling diagnostics, pharma, and academic research, food, and veterinary research as well as forensics. Through its REMP subsidiary, Tecan is the leading supplier of compound and sample storage, management, and logistics solutions. Tecan clients are diagnostic laboratories, pharmaceutical and biotechnology companies, and university research departments.

VWR's business is highly diversified across a spectrum of products and services, customer groups, and geography. The company's primary customers work in the pharmaceutical, life science, chemical, technology, food processing, and consumer product industries. Other customers include universities and research institutes, governmental agencies, and environmental testing organizations.


Related Links:
Tecan
VWR International, Inc

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.